Japan made seminal contributions to PBC research during 1990-2010, most notably through: (1) development of the IL-2R alpha /CD25-deficient mouse model that revolutionized autoimmune cholangitis studies, and (2) comprehensive characterization of anti-gp210 autoantibodies as specific diagnostic markers [33,34]. Here, IL2RA is linked to primary biliary cholangitis.